| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 9.85e-10 | 114 | 150 | 11 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 2.43e-09 | 124 | 150 | 11 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 6.99e-09 | 137 | 150 | 11 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 CTSD USP17L8 USP17L13 | 2.40e-08 | 192 | 150 | 12 | GO:0008234 |
| GeneOntologyMolecularFunction | sodium ion binding | 2.89e-06 | 14 | 150 | 4 | GO:0031402 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 8.03e-06 | 37 | 150 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 8.62e-06 | 18 | 150 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 4.02e-05 | 26 | 150 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 4.02e-05 | 26 | 150 | 4 | GO:0031420 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 5.44e-05 | 28 | 150 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.68e-04 | 118 | 150 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | peptidase activity | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 ACE USP17L17 AFG3L2 USP17L6P USP17L3 USP17L22 CTSD USP17L8 USP17L13 | 4.24e-04 | 654 | 150 | 14 | GO:0008233 |
| GeneOntologyMolecularFunction | sodium channel activity | 6.26e-04 | 52 | 150 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNAH10 RTEL1 MYO9A MYO9B CECR2 ANXA5 RHOBTB3 DNAH2 ABCC5 DNAH1 ABCG4 AFG3L2 DNAH6 | 7.55e-04 | 614 | 150 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | protein kinase A binding | 9.47e-04 | 58 | 150 | 4 | GO:0051018 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 1.77e-09 | 125 | 149 | 11 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 7.92e-09 | 144 | 149 | 11 | GO:0070646 |
| GeneOntologyBiologicalProcess | positive regulation of early endosome to late endosome transport | 3.01e-05 | 9 | 149 | 3 | GO:2000643 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to early endosome | 4.27e-05 | 10 | 149 | 3 | GO:1902965 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to early endosome | 4.27e-05 | 10 | 149 | 3 | GO:1902966 | |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 4.47e-05 | 177 | 149 | 8 | GO:0030010 | |
| GeneOntologyBiologicalProcess | polarized epithelial cell differentiation | 6.19e-05 | 30 | 149 | 4 | GO:0030859 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | EZR DPYSL3 AHI1 USP17L2 PDGFRB SYNE1 DNAH2 RDX ARHGAP35 ITGB4 GSK3B DNAH1 ANLN TTLL1 SPAG17 | 1.06e-04 | 670 | 149 | 15 | GO:0120031 |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 1.08e-04 | 257 | 149 | 9 | GO:0007163 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to endosome | 1.27e-04 | 14 | 149 | 3 | GO:1905668 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.29e-04 | 36 | 149 | 4 | GO:0086010 | |
| GeneOntologyBiologicalProcess | cell projection assembly | EZR DPYSL3 AHI1 USP17L2 PDGFRB SYNE1 DNAH2 RDX ARHGAP35 ITGB4 GSK3B DNAH1 ANLN TTLL1 SPAG17 | 1.35e-04 | 685 | 149 | 15 | GO:0030031 |
| GeneOntologyBiologicalProcess | regulation of protein localization to endosome | 1.58e-04 | 15 | 149 | 3 | GO:1905666 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | DOCK2 PDGFRB MYO9A MYO9B ARHGAP26 RDX ARHGAP35 BNIP2 PLEKHG3 DEF6 | 1.58e-04 | 333 | 149 | 10 | GO:0051056 |
| GeneOntologyBiologicalProcess | protein localization to early endosome | 1.93e-04 | 16 | 149 | 3 | GO:1902946 | |
| GeneOntologyCellularComponent | inner dynein arm | 4.90e-07 | 10 | 148 | 4 | GO:0036156 | |
| GeneOntologyCellularComponent | T-tubule | 1.46e-06 | 79 | 148 | 7 | GO:0030315 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 5.34e-06 | 17 | 148 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | cilium | EZR ANO2 AHI1 DNAH10 STARD10 DNAH2 AMBRA1 PRAMEF17 ARHGAP35 PTCH1 ACE DNAH1 EFHC1 SAG PRKACG TTLL1 SPAG17 CATSPERG USH2A DNAH6 | 5.57e-06 | 898 | 148 | 20 | GO:0005929 |
| GeneOntologyCellularComponent | sarcolemma | 8.66e-06 | 190 | 148 | 9 | GO:0042383 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.72e-05 | 25 | 148 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | sodium channel complex | 4.99e-05 | 29 | 148 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L7 RPL27 USP17L4 FMO1 USP17L2 MBOAT1 USP17L1 SYNE1 USP17L10 PIGA USP17L17 FRRS1L USP17L6P USP17L3 ELOVL3 SEL1L2 USP17L22 KDSR RNF145 LMBRD1 USP17L8 USP17L13 OR2W6P | 5.93e-05 | 1327 | 148 | 23 | GO:0042175 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L7 RPL27 USP17L4 FMO1 USP17L2 MBOAT1 USP17L1 USP17L10 PIGA USP17L17 FRRS1L USP17L6P USP17L3 ELOVL3 SEL1L2 USP17L22 KDSR RNF145 LMBRD1 USP17L8 USP17L13 OR2W6P | 1.14e-04 | 1293 | 148 | 22 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L7 RPL27 USP17L4 FMO1 USP17L2 MBOAT1 USP17L1 USP17L10 PIGA USP17L17 FRRS1L USP17L6P USP17L3 ELOVL3 SEL1L2 USP17L22 KDSR RNF145 LMBRD1 USP17L8 USP17L13 OR2W6P | 1.22e-04 | 1299 | 148 | 22 | GO:0098827 |
| GeneOntologyCellularComponent | anchoring junction | EZR RPL27 AHI1 PDGFRB ANXA5 ARHGAP26 STARD10 AMBRA1 RDX TNS2 PTPRU LCP2 ITGB4 MSN SCN1A SCN2A DEF6 CDH5 | 1.91e-04 | 976 | 148 | 18 | GO:0070161 |
| GeneOntologyCellularComponent | cell tip | 2.20e-04 | 17 | 148 | 3 | GO:0051286 | |
| GeneOntologyCellularComponent | motile cilium | DNAH10 STARD10 DNAH2 PRAMEF17 ACE DNAH1 TTLL1 SPAG17 CATSPERG DNAH6 | 2.25e-04 | 355 | 148 | 10 | GO:0031514 |
| GeneOntologyCellularComponent | cell pole | 3.63e-04 | 20 | 148 | 3 | GO:0060187 | |
| GeneOntologyCellularComponent | dynein complex | 5.80e-04 | 54 | 148 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | axoneme | 6.95e-04 | 207 | 148 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 7.15e-04 | 208 | 148 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | actin-based cell projection | 8.38e-04 | 278 | 148 | 8 | GO:0098858 | |
| GeneOntologyCellularComponent | focal adhesion | 1.02e-03 | 431 | 148 | 10 | GO:0005925 | |
| GeneOntologyCellularComponent | cell-cell junction | EZR AHI1 ANXA5 STARD10 RDX PTPRU LCP2 MSN SCN1A SCN2A DEF6 CDH5 | 1.04e-03 | 591 | 148 | 12 | GO:0005911 |
| GeneOntologyCellularComponent | cell-substrate junction | 1.25e-03 | 443 | 148 | 10 | GO:0030055 | |
| GeneOntologyCellularComponent | cation channel complex | 1.45e-03 | 235 | 148 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.52e-03 | 378 | 148 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex, eIF3m | 1.73e-03 | 9 | 148 | 2 | GO:0071541 | |
| GeneOntologyCellularComponent | filopodium | 1.84e-03 | 123 | 148 | 5 | GO:0030175 | |
| HumanPheno | Focal hemiclonic seizure | 9.22e-06 | 25 | 61 | 5 | HP:0006813 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 2.30e-05 | 15 | 61 | 4 | HP:0007207 | |
| HumanPheno | Cogwheel rigidity | 3.28e-05 | 32 | 61 | 5 | HP:0002396 | |
| HumanPheno | Visually-induced seizure | 5.02e-05 | 18 | 61 | 4 | HP:0020216 | |
| HumanPheno | Limitation of knee mobility | 5.14e-05 | 35 | 61 | 5 | HP:0010501 | |
| HumanPheno | EEG with generalized polyspikes | 5.53e-05 | 7 | 61 | 3 | HP:0012001 | |
| HumanPheno | Abnormal knee physiology | 6.87e-05 | 87 | 61 | 7 | HP:0034670 | |
| HumanPheno | Photosensitive myoclonic seizure | 8.77e-05 | 8 | 61 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 8.77e-05 | 8 | 61 | 3 | HP:0200048 | |
| HumanPheno | Talipes valgus | 9.57e-05 | 21 | 61 | 4 | HP:0004684 | |
| HumanPheno | Reflex seizure | 1.16e-04 | 22 | 61 | 4 | HP:0020207 | |
| HumanPheno | Focal clonic seizure | 1.26e-04 | 42 | 61 | 5 | HP:0002266 | |
| HumanPheno | Rigidity | 1.91e-04 | 214 | 61 | 10 | HP:0002063 | |
| Domain | UCH | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 1.92e-10 | 71 | 146 | 10 | PF00443 |
| Domain | USP_2 | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 1.92e-10 | 71 | 146 | 10 | PS00973 |
| Domain | USP_3 | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 2.21e-10 | 72 | 146 | 10 | PS50235 |
| Domain | USP_dom | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 2.21e-10 | 72 | 146 | 10 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 2.21e-10 | 72 | 146 | 10 | IPR001394 |
| Domain | HABP4_PAI-RBP1 | 1.55e-09 | 16 | 146 | 6 | PF04774 | |
| Domain | HABP4_PAIRBP1-bd | 1.55e-09 | 16 | 146 | 6 | IPR006861 | |
| Domain | USP_CS | USP17L7 USP17L2 USP17L1 USP17L10 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 2.15e-09 | 66 | 146 | 9 | IPR018200 |
| Domain | USP_1 | USP17L7 USP17L4 USP17L2 USP17L10 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 3.69e-09 | 70 | 146 | 9 | PS00972 |
| Domain | Na_trans_cytopl | 5.31e-08 | 6 | 146 | 4 | PF11933 | |
| Domain | Na_trans_cytopl | 5.31e-08 | 6 | 146 | 4 | IPR024583 | |
| Domain | Na_channel_asu | 7.26e-07 | 10 | 146 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 7.26e-07 | 10 | 146 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 7.26e-07 | 10 | 146 | 4 | PF06512 | |
| Domain | ERM_C_dom | 1.86e-06 | 4 | 146 | 3 | IPR011259 | |
| Domain | ERM | 1.86e-06 | 4 | 146 | 3 | PF00769 | |
| Domain | ERM | 1.86e-06 | 4 | 146 | 3 | IPR011174 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.38e-06 | 14 | 146 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.38e-06 | 14 | 146 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.38e-06 | 14 | 146 | 4 | IPR013602 | |
| Domain | DHC_N2 | 3.38e-06 | 14 | 146 | 4 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 3.38e-06 | 14 | 146 | 4 | IPR011704 | |
| Domain | MT | 3.38e-06 | 14 | 146 | 4 | PF12777 | |
| Domain | AAA_8 | 3.38e-06 | 14 | 146 | 4 | PF12780 | |
| Domain | AAA_5 | 3.38e-06 | 14 | 146 | 4 | PF07728 | |
| Domain | DHC_fam | 4.57e-06 | 15 | 146 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 4.57e-06 | 15 | 146 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.57e-06 | 15 | 146 | 4 | IPR004273 | |
| Domain | Moesin_tail | 1.60e-05 | 7 | 146 | 3 | IPR008954 | |
| Domain | IQ | 4.12e-05 | 81 | 146 | 6 | SM00015 | |
| Domain | Transmembrane_161A/B | 6.07e-05 | 2 | 146 | 2 | IPR019395 | |
| Domain | Tmemb_161AB | 6.07e-05 | 2 | 146 | 2 | PF10268 | |
| Domain | DUF3512 | 6.07e-05 | 2 | 146 | 2 | IPR021900 | |
| Domain | EIF3C_N_dom | 6.07e-05 | 2 | 146 | 2 | IPR008905 | |
| Domain | eIF-3c_N | 6.07e-05 | 2 | 146 | 2 | PF05470 | |
| Domain | DUF3512 | 6.07e-05 | 2 | 146 | 2 | PF12024 | |
| Domain | EIF3C | 6.07e-05 | 2 | 146 | 2 | IPR027516 | |
| Domain | IQ_motif_EF-hand-BS | 7.47e-05 | 90 | 146 | 6 | IPR000048 | |
| Domain | Channel_four-helix_dom | 8.23e-05 | 57 | 146 | 5 | IPR027359 | |
| Domain | - | 8.23e-05 | 57 | 146 | 5 | 1.20.120.350 | |
| Domain | IQ | 8.97e-05 | 93 | 146 | 6 | PS50096 | |
| Domain | BROMODOMAIN_1 | 1.94e-04 | 37 | 146 | 4 | PS00633 | |
| Domain | Bromodomain | 2.15e-04 | 38 | 146 | 4 | PF00439 | |
| Domain | IQ | 2.34e-04 | 71 | 146 | 5 | PF00612 | |
| Domain | BROMODOMAIN_2 | 2.90e-04 | 41 | 146 | 4 | PS50014 | |
| Domain | Bromodomain | 3.18e-04 | 42 | 146 | 4 | IPR001487 | |
| Domain | BROMO | 3.18e-04 | 42 | 146 | 4 | SM00297 | |
| Domain | - | 3.18e-04 | 42 | 146 | 4 | 1.20.920.10 | |
| Domain | Ez/rad/moesin-like | 5.61e-04 | 21 | 146 | 3 | IPR000798 | |
| Domain | FERM_CS | 8.40e-04 | 24 | 146 | 3 | IPR019747 | |
| Domain | AAA | 9.48e-04 | 144 | 146 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 9.48e-04 | 144 | 146 | 6 | IPR003593 | |
| Domain | FERM_C | 1.07e-03 | 26 | 146 | 3 | PF09380 | |
| Domain | FERM_PH-like_C | 1.19e-03 | 27 | 146 | 3 | IPR018980 | |
| Domain | FERM_C | 1.19e-03 | 27 | 146 | 3 | SM01196 | |
| Domain | RhoGAP | 1.41e-03 | 62 | 146 | 4 | SM00324 | |
| Domain | RhoGAP | 1.49e-03 | 63 | 146 | 4 | PF00620 | |
| Domain | RhoGAP_dom | 1.58e-03 | 64 | 146 | 4 | IPR000198 | |
| Domain | ZF_DAG_PE_1 | 1.58e-03 | 64 | 146 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.58e-03 | 64 | 146 | 4 | PS50081 | |
| Domain | RHOGAP | 1.58e-03 | 64 | 146 | 4 | PS50238 | |
| Domain | - | 1.58e-03 | 64 | 146 | 4 | 1.10.555.10 | |
| Domain | DHC_N1 | 1.65e-03 | 8 | 146 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.65e-03 | 8 | 146 | 2 | IPR013594 | |
| Domain | C1 | 1.68e-03 | 65 | 146 | 4 | SM00109 | |
| Domain | PE/DAG-bd | 1.77e-03 | 66 | 146 | 4 | IPR002219 | |
| Domain | Ion_trans_dom | 2.02e-03 | 114 | 146 | 5 | IPR005821 | |
| Domain | Ion_trans | 2.02e-03 | 114 | 146 | 5 | PF00520 | |
| Domain | FERM_N | 2.15e-03 | 33 | 146 | 3 | IPR018979 | |
| Domain | FERM_N | 2.15e-03 | 33 | 146 | 3 | PF09379 | |
| Domain | - | 3.48e-03 | 39 | 146 | 3 | 2.120.10.30 | |
| Domain | Rho_GTPase_activation_prot | 5.03e-03 | 88 | 146 | 4 | IPR008936 | |
| Domain | Acyl_CoA_acyltransferase | 5.22e-03 | 45 | 146 | 3 | IPR016181 | |
| Domain | FERM_M | 5.56e-03 | 46 | 146 | 3 | PF00373 | |
| Domain | 6-blade_b-propeller_TolB-like | 5.56e-03 | 46 | 146 | 3 | IPR011042 | |
| Domain | LY | 5.96e-03 | 15 | 146 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 5.96e-03 | 15 | 146 | 2 | IPR000033 | |
| Domain | PH_dom-like | 6.38e-03 | 426 | 146 | 9 | IPR011993 | |
| Domain | - | 6.63e-03 | 49 | 146 | 3 | 1.20.80.10 | |
| Domain | FERM_central | 6.63e-03 | 49 | 146 | 3 | IPR019748 | |
| Domain | FERM_domain | 6.63e-03 | 49 | 146 | 3 | IPR000299 | |
| Domain | P-loop_NTPase | DRG2 DNAH10 RTEL1 MYO9A MYO9B RHOBTB3 DNAH2 ABCC5 PFKFB2 ARHGAP35 DNAH1 ABCG4 AFG3L2 DNAH6 | 6.69e-03 | 848 | 146 | 14 | IPR027417 |
| Domain | PINT | 6.78e-03 | 16 | 146 | 2 | SM00088 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 7.01e-03 | 50 | 146 | 3 | IPR014352 | |
| Domain | FERM_1 | 7.01e-03 | 50 | 146 | 3 | PS00660 | |
| Domain | FERM_2 | 7.01e-03 | 50 | 146 | 3 | PS00661 | |
| Domain | FERM_3 | 7.01e-03 | 50 | 146 | 3 | PS50057 | |
| Domain | Band_41_domain | 7.01e-03 | 50 | 146 | 3 | IPR019749 | |
| Domain | B41 | 7.01e-03 | 50 | 146 | 3 | SM00295 | |
| Domain | PCI_dom | 7.64e-03 | 17 | 146 | 2 | IPR000717 | |
| Domain | PCI | 7.64e-03 | 17 | 146 | 2 | PF01399 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 1.02e-13 | 45 | 122 | 11 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L7 USP17L4 USP17L2 USP17L1 PSMD8 USP17L10 USP17L17 USP17L6P USP17L3 TNKS USP17L22 USP17L8 USP17L13 | 1.04e-08 | 191 | 122 | 13 | MM15289 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L7 USP17L4 USP17L2 USP17L1 PSMD8 USP17L10 USP17L17 USP17L6P USP17L3 TNKS USP17L22 USP17L8 USP17L13 | 4.25e-07 | 262 | 122 | 13 | MM15286 |
| Pathway | WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY | 2.51e-06 | 12 | 122 | 4 | M45558 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L4 USP17L2 USP17L1 PSMD8 USP17L10 USP17L17 USP17L3 TNKS USP17L22 USP17L8 USP17L13 | 3.35e-06 | 221 | 122 | 11 | M27578 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L7 USP17L4 USP17L2 USP17L1 PDGFRB PSMD8 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 3.71e-06 | 318 | 122 | 13 | MM15278 |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 3.19e-05 | 142 | 122 | 8 | MM15576 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 4.50e-05 | 149 | 122 | 8 | M41805 | |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L4 USP17L2 USP17L1 PSMD8 USP17L10 USP17L17 USP17L3 TNKS USP17L22 USP17L8 USP17L13 | 5.65e-05 | 299 | 122 | 11 | M27574 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 8.03e-05 | 27 | 122 | 4 | M47755 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 8.55e-05 | 121 | 122 | 7 | M872 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.40e-04 | 31 | 122 | 4 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.59e-04 | 32 | 122 | 4 | M27455 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 3.23e-04 | 69 | 122 | 5 | MM15596 | |
| Pathway | BIOCARTA_SHH_PATHWAY | 3.26e-04 | 16 | 122 | 3 | M11792 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 3.45e-04 | 70 | 122 | 5 | M41806 | |
| Pathway | WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS | 3.94e-04 | 17 | 122 | 3 | M39525 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | EZR RPL27 DPYSL3 MYO9B RDX PSMD8 ARHGAP35 GSK3B MSN SCN1A SCN2A SCN3A SCN9A PRKACG | 4.46e-04 | 575 | 122 | 14 | M29853 |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 5.08e-04 | 43 | 122 | 4 | M47669 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 5.54e-04 | 19 | 122 | 3 | M22005 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 6.05e-04 | 45 | 122 | 4 | M47670 | |
| Pathway | WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II | 7.30e-04 | 5 | 122 | 2 | M45547 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 2.42e-21 | 21 | 151 | 11 | 8622927 |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 2.42e-21 | 21 | 151 | 11 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 2.42e-21 | 21 | 151 | 11 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 2.42e-21 | 21 | 151 | 11 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 2.42e-21 | 21 | 151 | 11 | 12447969 |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 2.42e-21 | 21 | 151 | 11 | 18980247 | |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 4.83e-21 | 22 | 151 | 11 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 1.70e-20 | 24 | 151 | 11 | 8995226 |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 3.02e-20 | 25 | 151 | 11 | 21115691 | |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 5.21e-20 | 26 | 151 | 11 | 35816173 | |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 2.31e-19 | 29 | 151 | 11 | 32527007 | |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 1.27e-18 | 33 | 151 | 11 | 20228807 | |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 1.87e-18 | 34 | 151 | 11 | 20403174 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 1.87e-18 | 34 | 151 | 11 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 1.87e-18 | 34 | 151 | 11 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 1.87e-18 | 34 | 151 | 11 | 19188362 |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 1.87e-18 | 34 | 151 | 11 | 11941478 | |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 1.87e-18 | 34 | 151 | 11 | 17109758 | |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 1.87e-18 | 34 | 151 | 11 | 20388806 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 1.87e-18 | 34 | 151 | 11 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 1.87e-18 | 34 | 151 | 11 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 1.87e-18 | 34 | 151 | 11 | 20368735 |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 1.87e-18 | 34 | 151 | 11 | 10936051 | |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 1.87e-18 | 34 | 151 | 11 | 21448158 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 2.72e-18 | 35 | 151 | 11 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 2.72e-18 | 35 | 151 | 11 | 21239494 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 PRAMEF17 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 3.03e-18 | 50 | 151 | 12 | 31806660 |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 3.90e-18 | 36 | 151 | 11 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 5.54e-18 | 37 | 151 | 11 | 20228808 |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 3.00e-15 | 10 | 151 | 7 | 24207026 | |
| Pubmed | 1.97e-14 | 12 | 151 | 7 | 24695638 | ||
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | 8.45e-14 | 14 | 151 | 7 | 11793228 | |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | 1.22e-12 | 19 | 151 | 7 | 28067227 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 8812438 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 5.09e-09 | 6 | 151 | 4 | 23652591 | |
| Pubmed | 4.23e-08 | 9 | 151 | 4 | 16382098 | ||
| Pubmed | Finding the Unicorn, a New Mouse Model of Midfacial Clefting. | 4.23e-08 | 9 | 151 | 4 | 31940751 | |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 NDN PRAMEF17 USP17L17 SCN2A SCN3A USP17L6P USP17L3 USP17L22 CATSPERG USP17L8 USP17L13 | 4.52e-08 | 674 | 151 | 16 | 37196079 | |
| Pubmed | A neurogenomics approach to gene expression analysis in the developing brain. | 6.27e-08 | 170 | 151 | 9 | 15582152 | |
| Pubmed | 6.72e-08 | 81 | 151 | 7 | 12838346 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 19284629 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 8479753 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 18261459 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 21659656 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 19064715 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 21864676 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 14613898 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 33895391 | ||
| Pubmed | Inhibition of cell adhesion by phosphorylated Ezrin/Radixin/Moesin. | 8.02e-08 | 3 | 151 | 3 | 26555866 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 23859570 | ||
| Pubmed | Human ezrin-moesin-radixin proteins modulate hepatitis C virus infection. | 8.02e-08 | 3 | 151 | 3 | 23703860 | |
| Pubmed | Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation. | 8.02e-08 | 3 | 151 | 3 | 16889625 | |
| Pubmed | Effect of knockdown of ezrin, radixin, and moesin on P-glycoprotein function in HepG2 cells. | 8.02e-08 | 3 | 151 | 3 | 21837648 | |
| Pubmed | Ezrin and moesin function together to promote T cell activation. | 8.02e-08 | 3 | 151 | 3 | 19124745 | |
| Pubmed | Activation of Ras requires the ERM-dependent link of actin to the plasma membrane. | 8.02e-08 | 3 | 151 | 3 | 22132106 | |
| Pubmed | Ezrin-radixin-moesin family proteins are involved in parvovirus replication and spreading. | 8.02e-08 | 3 | 151 | 3 | 19321616 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 29906485 | ||
| Pubmed | Activation of PKC induces leukocyte adhesion by the dephosphorylation of ERM. | 8.02e-08 | 3 | 151 | 3 | 31843195 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 12610651 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 21278069 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 18784617 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 17544618 | ||
| Pubmed | Nuclear ERM (ezrin, radixin, moesin) proteins: regulation by cell density and nuclear import. | 8.02e-08 | 3 | 151 | 3 | 15149851 | |
| Pubmed | ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells. | 8.02e-08 | 3 | 151 | 3 | 21352885 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 1429901 | ||
| Pubmed | ERM Proteins at the Crossroad of Leukocyte Polarization, Migration and Intercellular Adhesion. | 8.02e-08 | 3 | 151 | 3 | 32098334 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 18295815 | ||
| Pubmed | Dmoesin controls actin-based cell shape and polarity during Drosophila melanogaster oogenesis. | 8.02e-08 | 3 | 151 | 3 | 12360288 | |
| Pubmed | Dynamics and function of ERM proteins during cytokinesis in human cells. | 8.02e-08 | 3 | 151 | 3 | 28889652 | |
| Pubmed | Control of adipogenesis by ezrin, radixin and moesin-dependent biomechanics remodeling. | 8.02e-08 | 3 | 151 | 3 | 23116763 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 21451358 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 14973256 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 20679347 | ||
| Pubmed | Differential expression and distribution of ezrin, radixin and moesin in human natural killer cells. | 8.02e-08 | 3 | 151 | 3 | 12385025 | |
| Pubmed | Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies? | 8.02e-08 | 3 | 151 | 3 | 25286001 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 17977945 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 15252013 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 32160548 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 12734202 | ||
| Pubmed | Alpha6beta4 integrin and dystroglycan cooperate to stabilize the myelin sheath. | 1.64e-07 | 12 | 151 | 4 | 18579745 | |
| Pubmed | 2.37e-07 | 13 | 151 | 4 | 15123669 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 17537961 | ||
| Pubmed | CPI-17 drives oncogenic Ras signaling in human melanomas via Ezrin-Radixin-Moesin family proteins. | 3.20e-07 | 4 | 151 | 3 | 27793041 | |
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 15096511 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 17237445 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 15178693 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 20660156 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 19129194 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 31018575 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 24760896 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 35801810 | ||
| Pubmed | Spatial regulation of cyclic AMP-Epac1 signaling in cell adhesion by ERM proteins. | 3.20e-07 | 4 | 151 | 3 | 20855527 | |
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 35031483 | ||
| Pubmed | Functional binding interaction identified between the axonal CAM L1 and members of the ERM family. | 3.20e-07 | 4 | 151 | 3 | 12070130 | |
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 29578003 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 19890007 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 28302370 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 22685202 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 21289089 | ||
| Pubmed | The ERM proteins interact with the HOPS complex to regulate the maturation of endosomes. | 3.20e-07 | 4 | 151 | 3 | 21148287 | |
| Cytoband | 8p23.1 | 8.58e-07 | 154 | 151 | 7 | 8p23.1 | |
| Cytoband | 4p16.1 | 6.67e-06 | 79 | 151 | 5 | 4p16.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 1.35e-05 | 234 | 151 | 7 | chr8p23 | |
| Cytoband | 2q24 | 5.80e-04 | 11 | 151 | 2 | 2q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 8.49e-04 | 127 | 151 | 4 | chr2q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | 8.73e-04 | 222 | 151 | 5 | chr4p16 | |
| Cytoband | 2q24.3 | 1.25e-03 | 16 | 151 | 2 | 2q24.3 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 8.83e-08 | 9 | 95 | 4 | 1203 | |
| GeneFamily | Dyneins, axonemal | 1.62e-06 | 17 | 95 | 4 | 536 | |
| GeneFamily | Myosins, class IX | 2.73e-05 | 2 | 95 | 2 | 1103 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 2.71e-12 | 86 | 151 | 11 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 5.12e-11 | 112 | 151 | 11 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 CD68 USP17L22 USP17L8 USP17L13 | 1.59e-10 | 160 | 151 | 12 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L7 USP17L4 USP17L2 USP17L1 STARD10 USP17L10 ITGB4 USP17L17 CTR9 USP17L6P USP17L3 CD68 TTLL1 USP17L22 USP17L8 USP17L13 | 1.11e-06 | 647 | 151 | 16 | MM981 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L7 USP17L4 USP17L2 USP17L1 KDM5C USP17L10 LCP2 BNIP2 PBRM1 CNOT6L USP17L17 USP17L6P USP17L3 TOMM34 ACOT2 USP17L22 CTSD USP17L8 USP17L13 | 1.37e-05 | 1072 | 151 | 19 | MM1031 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ANO2 DNAH10 LRP1B PKHD1L1 DNAH1 SLITRK2 SCN2A SCN9A ROS1 SPAG17 USH2A | 3.60e-11 | 184 | 150 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ANO2 DNAH10 LRP1B PKHD1L1 DNAH1 SLITRK2 SCN2A SCN9A ROS1 SPAG17 USH2A | 3.60e-11 | 184 | 150 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ANO2 DNAH10 LRP1B PKHD1L1 DNAH1 SLITRK2 SCN2A SCN9A ROS1 SPAG17 USH2A | 3.60e-11 | 184 | 150 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-09 | 169 | 150 | 9 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.60e-08 | 188 | 150 | 9 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-08 | 160 | 150 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-08 | 160 | 150 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-07 | 183 | 150 | 8 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 2.15e-07 | 184 | 150 | 8 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.10e-07 | 193 | 150 | 8 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 4.06e-07 | 200 | 150 | 8 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-06 | 162 | 150 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-06 | 163 | 150 | 7 | cab65dabeea58141c649e4fec5e0123beb3de1b3 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 175 | 150 | 7 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.6.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-06 | 177 | 150 | 7 | 929cd8f530ce001623735da53b7278d02522e2b5 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-06 | 182 | 150 | 7 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 3.07e-06 | 184 | 150 | 7 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-06 | 185 | 150 | 7 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | Thalamus-Endothelial|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.29e-06 | 186 | 150 | 7 | dcc6e4417c4123d5ca6b96fa8ca4874626aaebdb | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.41e-06 | 187 | 150 | 7 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-06 | 189 | 150 | 7 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-06 | 189 | 150 | 7 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-06 | 191 | 150 | 7 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | Ciliated-cil-3|World / Class top | 4.06e-06 | 192 | 150 | 7 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.81e-06 | 197 | 150 | 7 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.81e-06 | 197 | 150 | 7 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.81e-06 | 197 | 150 | 7 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.81e-06 | 197 | 150 | 7 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | 4.97e-06 | 198 | 150 | 7 | 33f0a919188a67d2a876b52c61a1cec2c9747969 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 4.97e-06 | 198 | 150 | 7 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 4.97e-06 | 198 | 150 | 7 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.14e-06 | 199 | 150 | 7 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | COVID-19-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 5.31e-06 | 200 | 150 | 7 | a60346c5ea7a3dae1ad3c5dc6c6eca65b64c6888 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-06 | 145 | 150 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 159 | 150 | 6 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 159 | 150 | 6 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 2.27e-05 | 168 | 150 | 6 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.35e-05 | 169 | 150 | 6 | 41ad349806b279fbe1374b7e3cc7f146a11adb44 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-05 | 169 | 150 | 6 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-05 | 169 | 150 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.35e-05 | 169 | 150 | 6 | 42782c61592742190ab0cba8a94f8bdf9c278f90 | |
| ToppCell | Endothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.59e-05 | 172 | 150 | 6 | 8a527dff06d841a86c7eb04a1dd9630787294da4 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-05 | 173 | 150 | 6 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-05 | 173 | 150 | 6 | 26bba58f9fb215d1d155504906cd77e8774f6936 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-05 | 173 | 150 | 6 | 69b404e92aad3e6dff67e75466f073f20a71f13f | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 2.68e-05 | 173 | 150 | 6 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 2.77e-05 | 174 | 150 | 6 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-05 | 175 | 150 | 6 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.95e-05 | 176 | 150 | 6 | 5914e7635474e7cf24d446bdb1423bc0807ee9c6 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 2.95e-05 | 176 | 150 | 6 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 2.95e-05 | 176 | 150 | 6 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | facs-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 177 | 150 | 6 | d4cd54c07f1e51b5485270348fb7195d53465027 | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.25e-05 | 179 | 150 | 6 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-05 | 180 | 150 | 6 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-05 | 180 | 150 | 6 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | P15-Endothelial-capillary_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.35e-05 | 180 | 150 | 6 | 63e7ec20a93452a02bf904acebdbe3d0d9ae8894 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-05 | 180 | 150 | 6 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-05 | 180 | 150 | 6 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.56e-05 | 182 | 150 | 6 | d22ab50b135482915687c70e6dad29bfe2bb2c68 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.67e-05 | 183 | 150 | 6 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.90e-05 | 185 | 150 | 6 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-05 | 185 | 150 | 6 | aa2c36e2cce0f0a536cd1dfc3788b6fee6f21b6b | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.02e-05 | 186 | 150 | 6 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.02e-05 | 186 | 150 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.02e-05 | 186 | 150 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.14e-05 | 187 | 150 | 6 | 12129e02638c20d9b7c1c6e512d48bfd966e1029 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.14e-05 | 187 | 150 | 6 | 83930ef55191eff9006113feaeabb3c2fa21fd05 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-05 | 187 | 150 | 6 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-05 | 187 | 150 | 6 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.27e-05 | 188 | 150 | 6 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-05 | 189 | 150 | 6 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-05 | 189 | 150 | 6 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-05 | 189 | 150 | 6 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 189 | 150 | 6 | 319e42f6e2322208de78bc666fb2c074707eb4da | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 4.53e-05 | 190 | 150 | 6 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 4.53e-05 | 190 | 150 | 6 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 4.53e-05 | 190 | 150 | 6 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.53e-05 | 190 | 150 | 6 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 190 | 150 | 6 | e64b191f928935484e2c993d7f8af0572a617a3a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 191 | 150 | 6 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 191 | 150 | 6 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 191 | 150 | 6 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 191 | 150 | 6 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | (12)_SLC16A7+|World / shred by cell type by condition | 4.66e-05 | 191 | 150 | 6 | e427eeddd2e87c14376a37db0b43f120c90436bc | |
| ToppCell | facs-Lung-Endomucin_-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.80e-05 | 192 | 150 | 6 | ba3fe97786564dba1c8185f2802ce1b57f4f3cc9 | |
| ToppCell | facs-Lung-Endomucin_|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.80e-05 | 192 | 150 | 6 | 85d4d0df701451daf95e94a87a0096da1e86533b | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.80e-05 | 192 | 150 | 6 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 193 | 150 | 6 | 2218833749576ba1a0fc95bd155c781e7e1163c6 | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 4.94e-05 | 193 | 150 | 6 | aa3acc7571405169efb656d214f3a8cbf988362e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.94e-05 | 193 | 150 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-05 | 194 | 150 | 6 | df56e23f1dcf1902d29392fcc947e0e268e1648b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.08e-05 | 194 | 150 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-05 | 194 | 150 | 6 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-05 | 194 | 150 | 6 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-05 | 194 | 150 | 6 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-05 | 195 | 150 | 6 | d9694db6bf239636d1335016878c98f6ee2eb0eb | |
| ToppCell | Mesenchymal_cells|World / Lineage and Cell class | 5.23e-05 | 195 | 150 | 6 | 380eb436baa371f7aa2dc0c4a594afb173b5a25b | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.23e-05 | 195 | 150 | 6 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 4.62e-16 | 46 | 150 | 11 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L7 USP17L4 USP17L2 USP17L1 USP17L10 USP17L17 USP17L6P USP17L3 USP17L22 USP17L8 USP17L13 | 5.72e-14 | 69 | 150 | 11 | DOID:1682 (implicated_via_orthology) |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.32e-07 | 10 | 150 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.32e-07 | 10 | 150 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.08e-07 | 12 | 150 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 4.37e-06 | 22 | 150 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.06e-05 | 9 | 150 | 3 | C3502809 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 2.57e-05 | 2 | 150 | 2 | C4551549 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 3.55e-05 | 13 | 150 | 3 | C0751122 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 5.08e-05 | 128 | 150 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 5.08e-05 | 128 | 150 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 5.08e-05 | 128 | 150 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 5.08e-05 | 128 | 150 | 6 | C1306837 | |
| Disease | Renal Cell Carcinoma | 5.08e-05 | 128 | 150 | 6 | C0007134 | |
| Disease | Pre-Eclampsia | 6.87e-05 | 16 | 150 | 3 | C0032914 | |
| Disease | Wilson disease (biomarker_via_orthology) | 7.68e-05 | 3 | 150 | 2 | DOID:893 (biomarker_via_orthology) | |
| Disease | middle cerebral artery infarction (implicated_via_orthology) | 8.13e-05 | 45 | 150 | 4 | DOID:3525 (implicated_via_orthology) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.14e-04 | 148 | 150 | 6 | C0279702 | |
| Disease | Leukemia, Myelomonocytic, Chronic | 3.80e-04 | 6 | 150 | 2 | C0023480 | |
| Disease | Manic Disorder | 4.78e-04 | 71 | 150 | 4 | C0024713 | |
| Disease | stomach cancer (is_implicated_in) | 5.05e-04 | 72 | 150 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | Seizure, Febrile, Simple | 5.30e-04 | 7 | 150 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 5.30e-04 | 7 | 150 | 2 | C0751057 | |
| Disease | Manic | 6.83e-04 | 78 | 150 | 4 | C0338831 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 7.04e-04 | 8 | 150 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 7.04e-04 | 8 | 150 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 7.04e-04 | 8 | 150 | 2 | C0338479 | |
| Disease | pneumococcal meningitis | 7.04e-04 | 8 | 150 | 2 | EFO_1001114 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 7.04e-04 | 8 | 150 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 7.04e-04 | 8 | 150 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 7.04e-04 | 8 | 150 | 2 | C0393703 | |
| Disease | Disorder of eye | 7.77e-04 | 212 | 150 | 6 | C0015397 | |
| Disease | facial height measurement | 8.14e-04 | 142 | 150 | 5 | EFO_0007856 | |
| Disease | Febrile Convulsions | 9.03e-04 | 9 | 150 | 2 | C0009952 | |
| Disease | Myoclonic Epilepsy | 9.03e-04 | 9 | 150 | 2 | C0014550 | |
| Disease | Autism Spectrum Disorders | 9.44e-04 | 85 | 150 | 4 | C1510586 | |
| Disease | Epilepsy, Myoclonic, Infantile | 1.12e-03 | 10 | 150 | 2 | C0917800 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 1.19e-03 | 41 | 150 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | cocaine use | 1.37e-03 | 11 | 150 | 2 | C3496069 | |
| Disease | Myoclonic Astatic Epilepsy | 1.37e-03 | 11 | 150 | 2 | C0393702 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 1.43e-03 | 95 | 150 | 4 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | epilepsy (implicated_via_orthology) | 1.50e-03 | 163 | 150 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | triacylglycerol 58:12 measurement | 1.64e-03 | 12 | 150 | 2 | EFO_0010439 | |
| Disease | Weight Gain | 1.85e-03 | 102 | 150 | 4 | C0043094 | |
| Disease | Amyotrophic Lateral Sclerosis, Familial | 1.88e-03 | 48 | 150 | 3 | C4551993 | |
| Disease | Amyotrophic Lateral Sclerosis, Sporadic | 1.88e-03 | 48 | 150 | 3 | C1862941 | |
| Disease | Kidney Failure, Chronic | 1.88e-03 | 48 | 150 | 3 | C0022661 | |
| Disease | Retinitis Pigmentosa | 1.99e-03 | 104 | 150 | 4 | C0035334 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 2.00e-03 | 49 | 150 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | Intellectual Disability | 2.11e-03 | 447 | 150 | 8 | C3714756 | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 2.12e-03 | 50 | 150 | 3 | C1862939 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.13e-03 | 106 | 150 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | Kuhnt-Junius degeneration (is_marker_for) | 2.24e-03 | 14 | 150 | 2 | DOID:10873 (is_marker_for) | |
| Disease | Epilepsy | 2.36e-03 | 109 | 150 | 4 | C0014544 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.44e-03 | 110 | 150 | 4 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.44e-03 | 110 | 150 | 4 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | interleukin 12 measurement | 2.50e-03 | 53 | 150 | 3 | EFO_0004753 | |
| Disease | MMR-related febrile seizures | 2.58e-03 | 15 | 150 | 2 | EFO_0006519 | |
| Disease | schizophrenia (biomarker_via_orthology) | 2.58e-03 | 15 | 150 | 2 | DOID:5419 (biomarker_via_orthology) | |
| Disease | cathepsin D measurement | 2.58e-03 | 15 | 150 | 2 | EFO_0010611 | |
| Disease | behavior | 2.78e-03 | 55 | 150 | 3 | GO_0007610 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 2.94e-03 | 16 | 150 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | Alpha ketoglutarate measurement | 2.94e-03 | 16 | 150 | 2 | EFO_0010457 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 2.94e-03 | 16 | 150 | 2 | C0393706 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.27e-03 | 195 | 150 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | muscular dystrophy (is_implicated_in) | 3.32e-03 | 17 | 150 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | BMI-adjusted waist circumference, physical activity measurement | 3.65e-03 | 123 | 150 | 4 | EFO_0007789, EFO_0008002 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 3.72e-03 | 18 | 150 | 2 | HP_0002373 | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 4.09e-03 | 63 | 150 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | Juvenile Myelomonocytic Leukemia | 4.15e-03 | 19 | 150 | 2 | C0349639 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 4.50e-03 | 301 | 150 | 6 | DOID:684 (is_marker_for) | |
| Disease | heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer | 4.59e-03 | 20 | 150 | 2 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004352, MONDO_0004992 | |
| Disease | alpha-tocopherol measurement | 4.59e-03 | 20 | 150 | 2 | EFO_0007898 | |
| Disease | Retinal Degeneration | 5.06e-03 | 21 | 150 | 2 | C0035304 | |
| Disease | social deprivation, COVID-19 | 5.06e-03 | 21 | 150 | 2 | EFO_0009696, MONDO_0100096 | |
| Disease | Infiltrating duct carcinoma of female breast | 5.06e-03 | 21 | 150 | 2 | C3165106 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FYEDSKLYQLVYLMN | 581 | Q6ZRH7 | |
| QDYIQSKIVYYLMNI | 231 | O60825 | |
| AYYLAKTMADVPFQV | 466 | Q9H172 | |
| QATYNKQPMYRKAIY | 356 | Q9Y6K1 | |
| RIYDYDPLYKEALQM | 311 | Q9UH17 | |
| EMGHIQYYLQYKDLP | 391 | P12821 | |
| NAMIYNKPETIYYKA | 206 | Q9NPI1 | |
| NAMTYNRPDTVYYKL | 211 | Q9H8M2 | |
| AQYLPKEQYLYTKEQ | 606 | Q9Y4W6 | |
| YYEKENVDYILPIMT | 391 | Q8N157 | |
| VYMAYKDLYQVSNTE | 166 | Q14195 | |
| IPELQEYVKYKYAMD | 56 | Q8WXK1 | |
| NSNYYAMDLLYILPT | 251 | P50416 | |
| AVMALAYYNYEDLPK | 246 | P49753 | |
| AYYNYEDLPKTMETL | 251 | P49753 | |
| GYVKYSIFQLVMQYL | 966 | A6QL63 | |
| VVLYSSDYYVKPVAM | 251 | P10523 | |
| SIPAYLAETLYYAMK | 246 | P08758 | |
| NLSYPFSREKMYLYN | 251 | Q9NQ90 | |
| LSPAAYYAQRMIQYL | 721 | Q9C0C7 | |
| PYNQTLTGYNDYIKM | 226 | Q01459 | |
| PMKPLDYEYIQQYSF | 321 | P33151 | |
| SYAPNYYQIIKAPMD | 466 | Q9BXF3 | |
| LQSIVPLFIYMNKFY | 221 | Q86Y37 | |
| IEKYIVPYMKQYEAH | 1686 | Q6ZS30 | |
| PQYMIDLYNRYTSDK | 86 | Q9UK05 | |
| KSLPMNYYTVFYHVQ | 371 | Q9UJ83 | |
| QYLPFSNKEYEISML | 1096 | Q92621 | |
| YLKIAQDLEMYGVNY | 191 | P35241 | |
| LAGNSMVVAIYAYYK | 56 | Q9NPB9 | |
| DDKVYPGEQYTYMLL | 146 | P00450 | |
| LQQKVVYLSYMAVEY | 231 | P34810 | |
| TPKYMNNITYYFDNV | 376 | Q6PKG0 | |
| KYPDYYQQIKMPISL | 416 | Q86U86 | |
| LYYPQMLYIRKISNI | 266 | Q5VTA0 | |
| NYSNPVYAKLYMDGQ | 4556 | Q9NZR2 | |
| QMNSPLQEYYVDYKP | 476 | Q86VH4 | |
| SYFYYLMSAVQPLNI | 996 | Q3T906 | |
| KELLNPIYGMFTYYQ | 756 | Q15034 | |
| LAPQYVMYGSQNYLI | 431 | Q9NUN5 | |
| TVQKPDAANYYYLII | 821 | Q9NQW6 | |
| RYNMYYSFAPTKLNE | 636 | Q9P1W3 | |
| NMYKQLGYSVYRTVI | 121 | P61599 | |
| IIYMYLQPANTYSQD | 261 | Q8NHA6 | |
| MNVYLKEDIPNRFYY | 291 | Q9Y6X5 | |
| YMKYLRQKNIPFYIS | 251 | Q969I3 | |
| DMLYPLYQKYKNAIT | 296 | A0PJZ3 | |
| FQSMYYPLQLKFLET | 391 | A0PJZ3 | |
| YLKIAQDLEMYGVNY | 191 | P26038 | |
| ISIYYDPMISKLITY | 441 | P05165 | |
| VELTNLYPYCDYEMK | 1181 | P16144 | |
| VYQIAMVHYIKQKYP | 281 | P20839 | |
| PTQLSYKYYFMSVNA | 561 | O60244 | |
| YYPKPVNMTKATVNY | 781 | Q92729 | |
| IYNYMLPSSYQTPEK | 256 | Q8NGZ9 | |
| KDNPHMQYYASIYAL | 906 | O15440 | |
| YILNMLFNLPETYLY | 121 | Q86YG4 | |
| SLYDYNPNLATYMKP | 381 | Q99613 | |
| GMYEAVNYYVLNPKS | 1891 | Q9P2D7 | |
| ASLYDYNPNLATYMK | 381 | B5ME19 | |
| IDPMYQYSLKYFKQL | 3311 | Q9C0G6 | |
| LQYMKHYFPINYKIS | 51 | Q6ZMJ4 | |
| FKDNSYLYLVMEYVP | 111 | P22612 | |
| MDVNGYSDPYVKTYL | 281 | Q14183 | |
| KPMNEYRSVVYYQVK | 471 | Q92608 | |
| MYTYYTLKAANVKPP | 181 | Q9HB03 | |
| IYKYEDIFMPSAAYQ | 256 | Q9P0K9 | |
| PIPEVLKNYMDAQYY | 66 | P07339 | |
| YVPNSQFLEYLKMYA | 81 | Q01740 | |
| DVKQVMPDQRVIYYY | 1196 | Q9HC77 | |
| MPDQRVIYYYAAAQT | 1201 | Q9HC77 | |
| QTLPVIYVKLYMYQL | 151 | P49841 | |
| KIEYMQQNLVRYYEL | 406 | Q9NWK9 | |
| YPNNYETMKILGSLY | 371 | Q6PD62 | |
| KDEYYSRPLQVMAAY | 61 | P28325 | |
| PNYRYLMDNLFKYVI | 181 | Q12982 | |
| QGYMPYLNKYILDKV | 66 | Q9H4E7 | |
| VEPTISLYKSMYFYL | 446 | Q6ZNC8 | |
| TEYLYANKMAFRYPE | 531 | P23368 | |
| ATLLESYQVYKRYQM | 286 | O95260 | |
| YVLKYMESNAAQYSP | 511 | Q5JVL4 | |
| YLKIAQDLEMYGINY | 191 | P15311 | |
| VTLVKYFPQAYMNFY | 276 | O60931 | |
| NLNSLFEKYVPYLMD | 2276 | Q8IVF4 | |
| YKIMVPTVDTVRYNY | 2386 | Q9P225 | |
| FVKVYNYNHLMPTRY | 71 | P61353 | |
| AIFIYAFPNYAAMKL | 2061 | O75923 | |
| QMEVKPYNVYITVAY | 201 | Q06136 | |
| VKYADIESSNYMAPY | 761 | P09619 | |
| PSNMYLKQLAEYRKY | 586 | O94955 | |
| NYTPYKYNLKNFMVI | 271 | Q93099 | |
| KQQADIIFMPYNYLL | 216 | Q9NZ71 | |
| VNTYSYTDVNLKPYM | 3456 | O75445 | |
| ADYIIMNYSVKHPKY | 141 | Q9Y365 | |
| AKQYVYIAVMDYLPI | 336 | Q8N7P1 | |
| YEVTYQILKQTAEMY | 556 | Q8NF91 | |
| EAYYYMLGPAKETNI | 121 | Q9NX61 | |
| VVYLVTEVYYNFMKP | 116 | Q8NDZ6 | |
| PVQLYKEMVDYSNTY | 496 | Q969F9 | |
| KEAILEMDSYYPNRY | 406 | A1L390 | |
| GQPLAIYYLAKMYAT | 441 | Q5TEA6 | |
| SPALLMQQFYNETYY | 41 | P22732 | |
| GMPISILYNKFSDYY | 486 | Q8TDN2 | |
| QELYRKYEMQYAPQP | 2681 | Q96Q15 | |
| KTISPYTMEGYLYVQ | 261 | Q9UNA1 | |
| YNMYIVTQKADYPNI | 801 | Q13635 | |
| VDKQPKYEYSLYMYI | 1421 | Q15858 | |
| YMQKEGDPVAYYRNL | 701 | Q9H156 | |
| QMYLYIQEVADYLTP | 436 | P53794 | |
| DVKLQPVYEENLYMY | 1431 | Q9NY46 | |
| RVYMPCLYVYNKIDQ | 236 | P55039 | |
| SRKMQASPEYQDYVY | 296 | Q9NRY4 | |
| AYGYNNIQMTLPKTY | 371 | Q9NSD9 | |
| TTEVDMRYYNYLLNP | 421 | Q6Q759 | |
| NVELQPKYEESLYMY | 1446 | P35498 | |
| LGIYMTYSPKVYSVN | 251 | Q6ZU45 | |
| KDYTQVDYLINGMYA | 431 | Q96F05 | |
| LKSAYENNLMPYTNY | 466 | Q96LI5 | |
| GLKVYYLPLKVMYNQ | 86 | P37287 | |
| YPNYMIINLDKLDYC | 41 | O95455 | |
| MQLSFTQLTIDYYPY | 351 | A0JNW5 | |
| YMSQQNTGPLVYVLY | 306 | A6NCW0 | |
| YPMAYVDYKTVLQID | 101 | Q15785 | |
| YMSQQNTGPLVYVLY | 306 | A6NCW7 | |
| ATYYNVDMLKYQVSA | 666 | Q9BQI5 | |
| ELTAKYLNYYQGMLD | 176 | Q92791 | |
| YPEYLITYQIMKPEA | 1301 | O95271 | |
| QMNTYVALYKFVPQE | 286 | Q99469 | |
| NVELQPKYEDNLYMY | 1436 | Q99250 | |
| LEMYSISRKYDYQQP | 81 | Q96E16 | |
| YMSQQNTGPLVYVLY | 306 | C9JLJ4 | |
| NLVIYLQRYMDPSTY | 101 | Q96G79 | |
| LMLKQIQYTAYGEIY | 2311 | Q9P273 | |
| YMIQIAVKNYYSDPL | 1526 | P08922 | |
| YMSQQNTGPLVYVLY | 306 | Q7RTZ2 | |
| NYFDGTYQMLYLLVK | 3911 | Q86WI1 | |
| YSVMINKATPYNYPV | 41 | O95167 | |
| YMSQQNTGPLVYVLY | 306 | P0C7H9 | |
| YMSQQNTGPLVYVLY | 306 | P0C7I0 | |
| IPSFERYMAQLKCYY | 161 | P48556 | |
| YMSQQNTGPLVYVLY | 306 | Q6QN14 | |
| YMSQQNTGPLVYVLY | 306 | D6RA61 | |
| YYLYDNAMCKEIIPT | 1486 | Q14669 | |
| NPLFQYKYLALNMHY | 46 | Q96MT1 | |
| YMSQQNTGPLVYVLY | 306 | D6RBQ6 | |
| FQPFLKIYQSMQLVY | 321 | Q63HR2 | |
| KIYQSMQLVYTSGVY | 326 | Q63HR2 | |
| YMSQQNTGPLVYVLY | 306 | Q6R6M4 | |
| NGKYLYLDFVPVTYM | 101 | O95922 | |
| YMSQQNTGPLVYVLY | 306 | C9JJH3 | |
| PAEAELYQYYLAQNM | 856 | Q15911 | |
| VQLIPLGSMSQYYYQ | 366 | Q96PN7 | |
| INYAKSLYYEQQLML | 4361 | Q5THJ4 | |
| VYPYEMYQSGANLVQ | 161 | P41229 | |
| TNPYVLMVLYKDKVY | 456 | Q13094 | |
| FLPIYNPKYVKMYDN | 191 | B2RTY4 | |
| FLPIYNPKYVKMYEN | 191 | Q13459 | |
| QMNYLKYQRVPYVEP | 241 | Q99608 |